Impaired Platelet Activation in Familial High Density Lipoprotein Deficiency (Tangier Disease)

This publication has 31 references indexed in Scilit:

• Suppression of Endothelial Cell Apoptosis by High Density Lipoproteins (HDL) and HDL-associated Lysosphingolipids
  Journal of Biological Chemistry, 2001
• ATP binding cassette transporter ABCA1 modulates the secretion of apolipoprotein E from human monocyte‐derived macrophages
  The FASEB Journal, 2001
• Transport of lipids from Golgi to plasma membrane is defective in Tangier disease patients and Abc1-deficient mice
  Nature Genetics, 2000
• Molecular Cloning of the Human ATP-Binding Cassette Transporter 1 (hABC1): Evidence for Sterol-Dependent Regulation in Macrophages
  Biochemical and Biophysical Research Communications, 1999
• Inhibition of platelet function by recombinant soluble ecto-ADPase/CD39.
  Journal of Clinical Investigation, 1998
• Aminophospholipid exposure, microvesiculation and abnormal protein tyrosine phosphorylation in the platelets of a patient with Scott syndrome: a study using physiologic agonists and local anaesthetics
  British Journal of Haematology, 1997
• Optimally functional fluorescein isothiocyanate‐labelled fibrinogen for quantitative studies of binding to activated platelets and platelet aggregation
  British Journal of Haematology, 1996
• Abnormal processing of Golgi elements and lysosomes in Tangier disease.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
• Transport of a fluorescent phosphatidylcholine analog from the plasma membrane to the Golgi apparatus.
  The Journal of cell biology, 1984
• Bile lipid composition and haemostatic variables in a case of high density lipoprotein deficiency (Tangier disease)
  European Journal of Clinical Investigation, 1984